The page lists 22 deliverables related to the research project "ICare".
title and desprition | type | last update |
---|---|---|
Report on status of posting results in the study registry for clinical study 4Report on the status of the result posting including timelines when final posting of results is scheduled after end of funding period Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Report on status of posting results in the study registry for clinical study 3Report on the status of the result posting including timelines when final posting of results is scheduled after end of funding period. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Report on status of posting results in the study registry for clinical study 2Report on the status of the result posting including timelines when final posting of results is scheduled after end of funding period Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Report on status of posting results in the study registry for clinical study 7Report on the status of the result posting including timelines when final posting of results is scheduled after end of funding period. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Report on status of posting results in the study registry for clinical study 6Report on the status of the result posting including timelines when final posting of results is scheduled after end of funding period. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
All approvals package for clinical study 4All approvals from ethics committees and national competent authorities of ALL study sites once the last approval has been received Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Report on status of posting results in the study registry for clinical study 5Report on the status of the result posting including timelines when final posting of results is scheduled after end of funding period Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
ICare WebsiteThe website will contain the collaboration and communication tools, and will describe the vision of the project as well as the structure and role of the partners and the specific section targeted to end users. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Websites, patent fillings, videos etc. | 2020-04-07 |
All approvals package for clinical study 2All approvals from ethics committees and national competent authorities of ALL study sites once the last approval has been received Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Submission package for clinical study 2Contains the final version of study protocol as submitted to regulators/ethics committee(s), the registration number of the clinical study in a WHO- or ICMJE-approved registry and the approvals (ethics committees and national competent authority if applicable) required for invitation/enrolment of first participant in at least one clinical centre. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
All approvals package for clinical study 6All approvals from ethics committees and national competent authorities of ALL study sites once the last approval has been received. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Submission package for clinical study 7Contains the final version of study protocol as submitted to regulators/ethics committee(s), the registration number of the clinical study in a WHO- or ICMJE-approved registry and the approvals (ethics committees and national competent authority if applicable) required for invitation/enrolment of first participant in at least one clinical centre. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
All approvals package for clinical study 3All approvals from ethics committees and national competent authorities of ALL study sites once the last approval has been received Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Submission package for clinical study 1Contains the final version of study protocol as submitted to regulators/ethics committee(s), the registration number of the clinical study in a WHO- or ICMJE-approved registry and the approvals (ethics committees and national competent authority if applicable) required for invitation/enrolment of first participant in at least one clinical centre. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Submission package for clinical study 6Contains the final version of study protocol as submitted to regulators/ethics committee(s), the registration number of the clinical study in a WHO- or ICMJE-approved registry and the approvals (ethics committees and national competent authority if applicable) required for invitation/enrolment of first participant in at least one clinical centre. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
All approvals package for clinical study 1All approvals from ethics committees and national competent authorities of ALL study sites once the last approval has been received Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
All approvals package for clinical study 7All approvals from ethics committees and national competent authorities of ALL study sites once the last approval has been received. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Submission package for clinical study 4Contains the final version of study protocol as submitted to regulators/ethics committee(s), the registration number of the clinical study in a WHO- or ICMJE-approved registry and the approvals (ethics committees and national competent authority if applicable) required for invitation/enrolment of first participant in at least one clinical centre Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Submission package for clinical study 3contains the final version of study protocol as submitted to regulators/ethics committee(s), the registration number of the clinical study in a WHO- or ICMJE-approved registry and the approvals (ethics committees and national competent authority if applicable) required for invitation/enrolment of first participant in at least one clinical centre Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
All approvals package for clinical study 5All approvals from ethics committees and national competent authorities of ALL study sites once the last approval has been received Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Submission package for clinical study 5Contains the final version of study protocol as submitted to regulators/ethics committee(s), the registration number of the clinical study in a WHO- or ICMJE-approved registry and the approvals (ethics committees and national competent authority if applicable) required for invitation/enrolment of first participant in at least one clinical centre. Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |
Report on status of posting results in the study registry for clinical study 1Report on the status of the result posting including timelines when final posting of results is scheduled after end of funding period Programme: H2020-EU.3.1.6. - Topic(s): PHC-23-2014 |
Documents, reports | 2020-04-07 |